JamtekiTM is the second biosimilar developed under this partnership that receives marketing authorization in Canada. Alvotech (NASDAQ: ALVO), a global...
PrJamtekiTM is the second biosimilar developed under this partnership that receives marketing authorization in Canada. REYKJAVIK, Iceland and BOUCHERVILLE, Quebec,...
ACTengine® IMA203 GEN1 TCR-T targeting PRAME showed 50% (6/12) confirmed ORR in melanoma patients with median duration of response (mDOR)...
Completed full enrollment and dosing of the 50 mg cohort in Phase 2 Friedreich's ataxia (FA) dose exploration trial; based...
FDA confirms need for new trial for avasopasem; GRECO trials with rucosopasem to be discontinued Company evaluating potential strategic options...
Company previously announced statistically significant topline TRV045 data from two proof-of-concept studies evaluating S1PR mechanism of action and CNS target...
Phase 1 dose escalation for VIP943 - first antibody-drug conjugate (ADC) from VersAptx™, versatile and adaptable, next-generation bioconjugation platform -...
DUBLIN, Nov. 13, 2023 /PRNewswire/ -- The "3-Hour Virtual Seminar on IEC 62304 - Medical Device Software Compliance" webinar has been added...
Nominates Didier Hirsch and Martin Madaus for election to the Board of Directors Upon the election of Messrs. Hirsch and Madaus, seven...
Gross profit percentage of 36% for the quarter, up 1% from first fiscal quarter 2024Total operating expenses decreased for the...
Long-term relationship will focus on the potential for new advancements to expand patient and clinician access and transform the approach...
Three New Members Bring Extensive Leadership and Industry Experience to Morphic MedicalBOSTON--(BUSINESS WIRE)--Morphic Medical, creator of the world’s first medical...
ATLANTA, GA and PRINCETON, NJ / ACCESSWIRE / November 13, 2023 / Florence Healthcare and WCG have announced a strategic...
Investor Call to be held Wednesday, November 15th at 11:00 AM Eastern TimeBOHEMIA, NY / ACCESSWIRE / November 13, 2023...
SAN MATEO, Calif.--(BUSINESS WIRE)--Model N, Inc. (NYSE: MODN), the leader in cloud revenue management solutions, today announced that Model N...
Red Light Holland's natural psilocybin microdosing capsules developed from psilocybin truffles grown in the Company's farm in The Netherlands, have...
MONTREAL, QC / ACCESSWIRE / November 13, 2023 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and...
– FDA feedback indicates Company’s CMC plans are in alignment with FDA’s requirements and expectations towards a BLA – –...
“Strategy is important. EXECUTION is everything.” Miami, FL, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST)...
Cash and cash equivalents of approximately $11.5 million as of October 31, 2023 Special meeting of stockholders on November 16 seeking...